Caljon G

Title : Selective and Orally Bioavailable Dipeptidyl Peptidase 9 Inhibitors with Potent Pyroptosis Induction Properties - Filippi_2025_J.Med.Chem__

Author(s) : Filippi N , Mertens K , De Loose J , Benramdane S , Hermans R , Espadinha M , Dirkx L , Feijens PB , Nozal V , Verhulst E , Peeters S , Gomard T , Corthaut S , Augustyns K , Caljon G , Schols D , De Meester I , Van der Veken P

Ref : Journal of Medicinal Chemistry , : , 2025

Abstract :

PubMedSearch : Filippi_2025_J.Med.Chem__

PubMedID: 41160575

Gene_locus related to this paper: human-DPP9

Title : Highly Selective Inhibitors of Dipeptidyl Peptidase 9 (DPP9) Derived from the Clinically Used DPP4-Inhibitor Vildagliptin - Benramdane_2023_J.Med.Chem__

Author(s) : Benramdane S , De Loose J , Filippi N , Espadinha M , Beyens O , Rymenant YV , Dirkx L , Bozdag M , Feijens PB , Augustyns K , Caljon G , De Winter H , De Meester I , Van der Veken P

Ref : Journal of Medicinal Chemistry , : , 2023

Abstract :

PubMedSearch : Benramdane_2023_J.Med.Chem__

PubMedID: 37721854

Caljon G

References (2)

1. Selective and Orally Bioavailable Dipeptidyl Peptidase 9 Inhibitors with Potent Pyroptosis Induction Properties - Filippi_2025_J.Med.Chem__

2. Highly Selective Inhibitors of Dipeptidyl Peptidase 9 (DPP9) Derived from the Clinically Used DPP4-Inhibitor Vildagliptin - Benramdane_2023_J.Med.Chem__